Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Miruku Limited currently manages 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This company patent portfolio activity is restricted to 1 distinct examiner working within 1 distinct art unit. This level of concentration means that the current prosecution efforts are focused on 1 point of contact at the USPTO. The 1 distinct art unit indicates a specific technical focus for the pending biotechnology application.
DELIA M RAMIREZ is the busiest examiner for this portfolio, currently overseeing 1 pending office action. Because she is the only 1 distinct examiner involved, her interpretation of the 1 pending office action is the sole factor in the current examination process. The 1 distinct art unit provides the regulatory and technical environment for this review. For Miruku Limited, the 1 pending office action represents the current extent of its active patent prosecution in this technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAMIREZ, DELIA M | 1 | 65.1% | +56.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723331 | MODIFIED DAIRY PROTEINS, METHODS FOR THEIR PRODUCTION AND USE | RAMIREZ, DELIA M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723331 | MODIFIED DAIRY PROTEINS, METHODS FOR THEIR PRODUCTION AND USE | RAMIREZ, DELIA M | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723331 | MODIFIED DAIRY PROTEINS, METHODS FOR THEIR PRODUCTION AND USE | RAMIREZ, DELIA M | 1652 | §101§102§103§112Other | Non-Final OA | — | Pending | Jun 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial